Myriad Genetics
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Myriad Genetics
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual’s risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
/ 
Frequently asked questions
To buy Myriad Genetics stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Myriad Genetics by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Myriad Genetics is MYGN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Myriad Genetics has its primary listing on NASDAQ. You can trade Myriad Genetics with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Myriad Genetics is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Myriad Genetics as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Myriad Genetics.